Anti-Mycoplasma pneumoniae antibody (FITC) (ab20361)


  • Product nameAnti-Mycoplasma pneumoniae antibody (FITC)
    See all Mycoplasma pneumoniae primary antibodies
  • Description
    Rabbit polyclonal to Mycoplasma pneumoniae (FITC)
  • ConjugationFITC. Ex: 493nm, Em: 528nm
  • SpecificityRecognises all antigens of Mycoplasma pneumoniae. Not reactive with bovine or human sera.
  • Tested applicationsSuitable for: ICC/IFmore details
  • Species reactivity
    Recognises Mycoplasma pneumoniae. Has not been absorbed and may react with related microorganisms.
  • Immunogen

    Purified Mycoplasma pneumoniae.

  • General notes

    Covalently coupled with high purity Isomer I of fluorescein isothiocyanate. Care is taken to ensure complete removal of any free fluorescein from the final product.


  • FormLiquid
  • Storage instructionsShipped at 4°C. Store at +4°C.
  • Storage bufferPreservative: 0.1% Sodium Azide
    Constituents: 10mg/ml BSA, 0.01M PBS, pH 7.2
  • Concentration information loading...
  • PurityProtein A purified
  • ClonalityPolyclonal
  • IsotypeIgG
  • Research areas


Our Abpromise guarantee covers the use of ab20361 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
  • Application notesIF: 1/10 - 1/50. Acetone fixation of the antigen source is recommended prior to staining.

    Enzyme amplification following reaction with FITC conjugate can also be accomplished utilizing enzyme-antibody conjugates specific to FITC

    Not tested in other applications.
    Optimal dilutions/concentrations should be determined by the end user.
  • Target

    • RelevanceMycoplasma pneumoniae is a very small bacterium, a member of the class Mollicutes, meaning soft skin. Along with the other members of this class (Acholeplasma, Anaeroplasma, Asteroleplasma, Spiroplasma, and Ureaplasma) Mycoplasma are characterized by their unusually small genome as well as their complete lack of a bacterial cell wall. M. pneumoniae is a common cause of mild pneumonia and usually affects people younger than 40. Various studies suggest that it causes 15 to 50% of all pneumonia in adults and an even higher percentage of pneumonia in school aged children. Beta lactam antibiotics such as penicillin and cycloserine are ineffective as they act specifically to disrupt the cell wall so alternative antibiotic therapies such as the use of polyenes may be required. People at highest risk of mycoplasma pneumonia infection include those living or working in crowded areas such as schools and homeless shelters, although many people who become infected have no identifiable risk factor. M. pneumoniae can be detected via serology, PCR or in cell culture assays.
    • Alternative names
      • bacterial pneumonia antibody
      • M. pneumoniae antibody

    References for Anti-Mycoplasma pneumoniae antibody (FITC) (ab20361)

    ab20361 has not yet been referenced specifically in any publications.

    Product Wall

    There are currently no Abreviews or Questions for ab20361.
    Please use the links above to contact us or submit feedback about this product.